SAN FRANCISCO--(BUSINESS WIRE)--Fluxion Biosciences, a leading developer of microfluidic systems for cellular analysis in life sciences research and drug discovery, today announced that it has received a $1.2 million NIH grant for the development of a multiplexed single-cell electroporation system. The Phase II SBIR grant continues the successful development that was funded by NIH as part of a Phase I project completed in 2006.
